Close Menu

NEW YORK – NeuMoDx received Emergency Use Authorization from the US Food and Drug Administration on Monday for a COVID-19 assay on its fully automated, mid- and high-throughput diagnostics systems, according to a document posted on the agency's website.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.